HRP20020687B1 - DERIVATI 8,8a-DIHIDRO-INDENO[1,2-d]TIAZOLA KOJI U POLOZAJU 2 NOSE SUPSTITUENTE SA SULFONAMIDNOM ILI SULFONSKOM STRUKTUROM, POSTUPAK ZA NJIHOVU PROIZVODNJU I NJIHOVA UPOTREBA KAO LIJEKA - Google Patents

DERIVATI 8,8a-DIHIDRO-INDENO[1,2-d]TIAZOLA KOJI U POLOZAJU 2 NOSE SUPSTITUENTE SA SULFONAMIDNOM ILI SULFONSKOM STRUKTUROM, POSTUPAK ZA NJIHOVU PROIZVODNJU I NJIHOVA UPOTREBA KAO LIJEKA

Info

Publication number
HRP20020687B1
HRP20020687B1 HR20020687A HRP20020687A HRP20020687B1 HR P20020687 B1 HRP20020687 B1 HR P20020687B1 HR 20020687 A HR20020687 A HR 20020687A HR P20020687 A HRP20020687 A HR P20020687A HR P20020687 B1 HRP20020687 B1 HR P20020687B1
Authority
HR
Croatia
Prior art keywords
alkyl
phenyl
pyridyl
thienyl
substituted
Prior art date
Application number
HR20020687A
Other languages
English (en)
Croatian (hr)
Inventor
Jaehne Gerhard
Lang Hans-Jochen
Gossel Matthias
Bickel Martin
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20020687A2 publication Critical patent/HRP20020687A2/hr
Publication of HRP20020687B1 publication Critical patent/HRP20020687B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
HR20020687A 2000-02-26 2001-02-13 DERIVATI 8,8a-DIHIDRO-INDENO[1,2-d]TIAZOLA KOJI U POLOZAJU 2 NOSE SUPSTITUENTE SA SULFONAMIDNOM ILI SULFONSKOM STRUKTUROM, POSTUPAK ZA NJIHOVU PROIZVODNJU I NJIHOVA UPOTREBA KAO LIJEKA HRP20020687B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10009311 2000-02-26
PCT/EP2001/001553 WO2001062747A1 (de) 2000-02-26 2001-02-13 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
HRP20020687A2 HRP20020687A2 (en) 2004-12-31
HRP20020687B1 true HRP20020687B1 (hr) 2011-01-31

Family

ID=7632679

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020687A HRP20020687B1 (hr) 2000-02-26 2001-02-13 DERIVATI 8,8a-DIHIDRO-INDENO[1,2-d]TIAZOLA KOJI U POLOZAJU 2 NOSE SUPSTITUENTE SA SULFONAMIDNOM ILI SULFONSKOM STRUKTUROM, POSTUPAK ZA NJIHOVU PROIZVODNJU I NJIHOVA UPOTREBA KAO LIJEKA

Country Status (29)

Country Link
US (2) US6352987B2 (cs)
EP (1) EP1261593B1 (cs)
JP (1) JP4950405B2 (cs)
KR (1) KR100763214B1 (cs)
CN (1) CN1173959C (cs)
AT (1) ATE248155T1 (cs)
AU (2) AU2001244136B2 (cs)
BR (1) BR0108631A (cs)
CA (1) CA2400704C (cs)
CZ (1) CZ301253B6 (cs)
DE (1) DE50100558D1 (cs)
DK (1) DK1261593T3 (cs)
EE (1) EE04963B1 (cs)
ES (1) ES2206412T3 (cs)
HK (1) HK1052515B (cs)
HR (1) HRP20020687B1 (cs)
HU (1) HU229137B1 (cs)
IL (1) IL151460A (cs)
MX (1) MXPA02007025A (cs)
NO (1) NO323400B1 (cs)
NZ (1) NZ520981A (cs)
PL (1) PL202763B1 (cs)
PT (1) PT1261593E (cs)
RS (1) RS49933B (cs)
RU (1) RU2263113C2 (cs)
SI (1) SI1261593T1 (cs)
SK (1) SK285571B6 (cs)
WO (1) WO2001062747A1 (cs)
ZA (1) ZA200206580B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7261482B2 (en) * 2004-01-21 2007-08-28 Silverbrook Research Pty Ltd Photofinishing system with slitting mechanism
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
ES2559319T3 (es) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CA2741125A1 (en) 2008-10-22 2010-04-29 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2010051206A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN105001219A (zh) 2011-02-25 2015-10-28 默沙东公司 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
CA2828346C (en) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
RU2015106909A (ru) 2012-08-02 2016-09-27 Мерк Шарп И Доум Корп. Антидиабетические трициклические соединения
WO2014130608A1 (en) 2013-02-22 2014-08-28 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US9650375B2 (en) 2013-03-14 2017-05-16 Merck Sharp & Dohme Corp. Indole derivatives useful as anti-diabetic agents
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
WO2018118670A1 (en) 2016-12-20 2018-06-28 Merck Sharp & Dohme Corp. Antidiabetic spirochroman compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174397A (en) * 1976-09-08 1979-11-13 Hoechst Aktiengesellschaft Thiazolidine derivatives
WO2000051997A1 (de) * 1999-02-26 2000-09-08 Aventis Pharma Deutschland Gmbh Polycyclische thiazol-systeme und ihre verwendung als anorektika

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CZ2001170A3 (cs) * 1999-07-03 2001-06-13 Aventis Pharma Gmbh Polycyklické thiazolidin-2-ylidenaminy, způsob jejich přípravy a léčivo, které je obsahuje
CZ20011111A3 (cs) * 1999-09-16 2001-07-11 Aventis Pharma Deutschland Gmbh Deriváty indeno-, nafto- a benzocyklohepťadihydrothiazolu, jejich příprava a použití jako anorektická léčiva

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174397A (en) * 1976-09-08 1979-11-13 Hoechst Aktiengesellschaft Thiazolidine derivatives
WO2000051997A1 (de) * 1999-02-26 2000-09-08 Aventis Pharma Deutschland Gmbh Polycyclische thiazol-systeme und ihre verwendung als anorektika

Also Published As

Publication number Publication date
WO2001062747A1 (de) 2001-08-30
JP2003531117A (ja) 2003-10-21
EE200200467A (et) 2003-12-15
NZ520981A (en) 2004-08-27
AU4413601A (en) 2001-09-03
ES2206412T3 (es) 2004-05-16
BR0108631A (pt) 2002-12-03
EP1261593A1 (de) 2002-12-04
MXPA02007025A (es) 2003-03-27
HU229137B1 (en) 2013-08-28
CN1406234A (zh) 2003-03-26
KR20020079897A (ko) 2002-10-19
CA2400704C (en) 2008-11-04
ATE248155T1 (de) 2003-09-15
ZA200206580B (en) 2003-05-15
SK12252002A3 (sk) 2003-03-04
EE04963B1 (et) 2008-02-15
DK1261593T3 (da) 2003-12-01
PL357195A1 (en) 2004-07-26
DE50100558D1 (de) 2003-10-02
CN1173959C (zh) 2004-11-03
RU2002125673A (ru) 2004-01-10
RS49933B (sr) 2008-09-29
HK1052515B (zh) 2005-04-22
EP1261593B1 (de) 2003-08-27
IL151460A (en) 2008-08-07
NO323400B1 (no) 2007-04-23
JP4950405B2 (ja) 2012-06-13
US6444669B1 (en) 2002-09-03
US20010039278A1 (en) 2001-11-08
AU2001244136B2 (en) 2005-04-14
PL202763B1 (pl) 2009-07-31
HUP0300304A2 (hu) 2003-06-28
NO20023977L (no) 2002-10-18
YU56402A (sh) 2005-11-28
US20020103231A1 (en) 2002-08-01
PT1261593E (pt) 2004-01-30
HRP20020687A2 (en) 2004-12-31
US6352987B2 (en) 2002-03-05
CZ20022861A3 (cs) 2002-11-13
CZ301253B6 (cs) 2009-12-23
HUP0300304A3 (en) 2004-10-28
NO20023977D0 (no) 2002-08-21
CA2400704A1 (en) 2001-08-30
HK1052515A1 (en) 2003-09-19
RU2263113C2 (ru) 2005-10-27
KR100763214B1 (ko) 2007-10-08
SI1261593T1 (en) 2004-02-29
SK285571B6 (sk) 2007-04-05

Similar Documents

Publication Publication Date Title
HRP20020687B1 (hr) DERIVATI 8,8a-DIHIDRO-INDENO[1,2-d]TIAZOLA KOJI U POLOZAJU 2 NOSE SUPSTITUENTE SA SULFONAMIDNOM ILI SULFONSKOM STRUKTUROM, POSTUPAK ZA NJIHOVU PROIZVODNJU I NJIHOVA UPOTREBA KAO LIJEKA
PL1996180T3 (pl) Pochodne benzamidu i pirydyloamidu jako czynniki antybakteryjne
ES2287826T3 (es) 2-azetidinonas sustituidas con hidroxi utiles como agentes hipocolesterolemicos.
EA200401613A1 (ru) Лекарственное средство для лечения рака
EA200600509A1 (ru) Соединения пиримидотиофена
ME00681B (me) Jedinjenje indola
AR070336A1 (es) Derivado tiazol y su uso como inhibidor de vap-1
NO20062517L (no) 2-cyanopyrrolidinkarboksamidforbindelse
CY1109835T1 (el) Πυρανονες χρησιμες ως αναστολεις της atm
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
NZ549003A (en) Thiazole derivative as an ALK5 inhibitor
ATE528285T1 (de) Neue n-(2-aminophenyl)benzamidderivate mit harnstoffstruktur
AR039690A1 (es) Difenilazetidinonas sustituidas por grupos acidos, medicamentos que comprenden estos compuestos y su uso
DE60127845D1 (de) Benzylidenthiazolidindione und ihre verwendung als antimykotische mittel
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
MX2024008480A (es) Compuesto heterociclico que contiene nitrogeno que tiene un efecto de activacion del factor 2 relacionado con el factor nuclear eritroide 2 (nrf2).
NO20030729D0 (no) Oksazolyl-arylpropionsyrederivater og deres anvendelse som PPAR-agonister
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
AR019925A1 (es) Tiazolidin-2-iliden aminas policiclicas, medicamentos que los comprenden, procedimientos para su preparacion y su empleo para la fabricacion demedicamentos
DE60306671D1 (de) Azoverbindungen
SE0001208D0 (sv) Novel compounds
DE60316780D1 (de) Modulatoren von peroxisome proliferator-aktivierten rezeptoren
AR044175A1 (es) Compuestos de cefemo
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
WO2004032861A3 (en) Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140103

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20150213